Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial
Flávia Vieira, Fernanda S. Correia‐Melo, Cassio Santos‐Lima, Breno Souza‐Marques, Gustavo C. Leal, Ana Paula Jesus‐Nunes, Rodrigo P. Mello, Ana Teresa Caliman‐Fontes, Igor D. Bandeira, Roberta Ferrari Marback, Manuela Telles, Felipe Coelho Argôlo, Daniel H. Lins-Silva, Mariana V.F. Echegaray, Graziele Beanes, Lucas Araújo-de-Freitas, Samantha S. Silva, Taiane de A. Cardoso, Flávio Kapczinski, Gustavo Turecki, Acioly L.T. Lacerda, Lucas C. Quarantini
Topics & Concepts
KetamineSuicidal ideationRandomized controlled trialDouble blindedMedicineAnesthesiaClinical trialPoison controlInternal medicineSuicide preventionEmergency medicinePlaceboAlternative medicinePathologyTreatment of Major DepressionTryptophan and brain disordersGenetic Neurodegenerative Diseases